TICAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ticar, and what generic alternatives are available?
Ticar is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.
Summary for TICAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Patent Applications: | 4,528 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TICAR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TICAR
US Patents and Regulatory Information for TICAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 062690-001 | Dec 19, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |